Exosome– tag –
-
Qatar Issues Stark Warning Against Unapproved Injectable Exosomes, Citing Lack of Scientific Basis and Safety Data
ILoveQatar.net Qatar Overview The Qatar Ministry of Public Health has issued a strong public warning against the use of unapproved injectable exosome products for both medical and cosmetic applications. The Ministry explicitly stated tha... -
Bio-Engine Launches New MSC Culture Media, Achieving 15.1-Hour Doubling Time and 2.8-Fold Exosome Yield Increase
BioEngine Sci-Tech Co, Ltd. China Overview Bio-Engine Sci-Tech Co, Ltd. announced the launch of two new Mesenchymal Stem Cell (MSC) culture medium products: the Omni-Expansion MSC Culture Kit and Exo MSC CD Exosome Expression Kit. Design... -
Taiwan’s ITRI Establishes Highly Stable iPSC-Based MSC and Exosome Manufacturing Platform to Advance Regenerative Medicine
Industrial Technology Research Institute (ITRI) Taiwan Overview Taiwan's Industrial Technology Research Institute (ITRI) has established a highly stable iPSC-based mesenchymal stem cell (MSC) and exosome manufacturing platform. This plat... -
Porton Advanced’s UC-MSC Cell Bank for Exosome Manufacturing Receives FDA Drug Master File (DMF) Acceptance
Morningstar USA Overview Porton Advanced, a CDMO, announced that its umbilical cord-derived mesenchymal stem cell (UC-MSC) cell bank for exosome manufacturing has received Drug Master File (DMF) acceptance from the U.S. FDA. This accepta... -
Unicorn Bioscience Report Projects Regenerative Medicine Market to Reach $58.4 Billion in 2026, Scaling to $360 Billion by 2034
Unicorn Bioscience USA Overview Unicorn Bioscience has published a market research report projecting the regenerative medicine market to reach approximately $58.4 billion in 2026, with an anticipated surge to $360 billion by 2034. This g... -
MSC-Derived Exosomes Emerge as Promising Cell-Free Regenerative Therapies, Driving Active Research in Arthritis, Chronic Wounds, and Inflammatory Diseases
Vertex AI Search USA Overview Mesenchymal Stem Cell (MSC)-derived exosomes are garnering significant attention in regenerative medicine as a cell-free therapeutic alternative, capable of delivering MSCs' potent regenerative and immunomod... -
FDA Issues Over Six Warning Letters for Unapproved Exosome Therapies in US, Citing Illegal Sales and Unsubstantiated Claims (2024-2026)
Medical Spa Locator USA Overview As of June 2026, no injectable exosome products have received FDA approval in the United States. The FDA has issued over six warning letters between 2024 and 2026 to manufacturers and distributors selling... -
Exosome Clinical Trials Hit ~90 Globally in 2026: Advancing Regenerative Medicine, Diagnostic Biomarkers, and Drug Delivery
OmniGenix USA Overview A new peer-reviewed analysis in 2026 reveals approximately 90 exosome-related human clinical trials registered globally, showcasing diverse applications from cancer diagnostics to joint repair. Exosomes are being i... -
Dermatology & Plastic Surgery Specialists Introduces Exosome Therapy for Anti-Aging: Harnessing Stem Cell Culture-Derived Extracellular Vesicles for Skin Regeneration
Dermatology & Plastic Surgery Specialists (Blog) USA Overview Dermatology & Plastic Surgery Specialists has introduced exosome therapy as an anti-aging treatment. This therapy utilizes extracellular vesicles to signal skin cells for ... -
Cell-Free Advantage: Exosome-Biomaterial Platforms Offer Safer Treatment for Diabetic Skin Infections, But Clinical Translation Remains Complex
International Journal of Nanomedicine (論文) Global Overview A recent review explores exosome-biomaterial platforms as a promising, safer alternative to cell therapies for diabetic skin infections. These 'cell-free' approaches address sa...
